On September 1 (Monday) another meeting of the Transparency Council.
We talk to prof. Grażyna Rydzewska, vice-president of the Polish Society of Gastroenterology and Marek Lichota, president of the association "Appetite for life".
The agenda includes: Preparation of an opinion on the validity of changes to the drug program B.61 "Treatment of patients with early childhood nephropathic cystinosis (ICD-10: E 72.0)". Preparation of opinions on draft health policy programs of local government units: • "Breast cancer prevention...
In line with the guidelines of the European Commission on the European plan to reduce gas demand, Medicines for Europe - an organization associating European pharmaceutical companies, which also includes National Drug Manufacturers (PZPPF), calls on the governments of EU countries to maintain...
Two new representatives of the National Health Fund joined the Economic Commission: Piotr Włodarczyk and Wojciech Modzelewski. • Chairman of the Economic Committee: prof. Mirosław Szeligowski • Deputy Chairman of the Economic Committee: Joanna Kilkowska • Secretary of the Economic Committee:...
The first clinic in Poland introduces an innovative method of ultrafast diagnosis of skin diseases.
July 14 this year During the meeting of the Committee on Petitions of the European Parliament in Brussels, Grzegorz Rychwalski, vice-president of Polish Medicines Manufacturers, emphasized that Europeans are not safe today, because 80% of the substances used in the production of drugs used in the...
Folded in May this year. by National Medicines Manufacturers to the European Parliament "Petition on the need to support the production of active substances for medicinal products in the EU territory" will be considered on July 14 this year. around 9.30 by the EP Petitions Committee.
Eisai and Biogen announced that the US Food and Drug Administration (FDA) will process as a matter of priority an application for the marketing of lecanemab, an anti-beta-amyloid antibody. The Agency has indicated 6 January next year as the target date for the publication of the decision. The...
The French drug manufacturer Sanofi wants to have a real impact on changes in the availability of therapy in low-income countries. And the word "impact" can be clearly emphasized here, because the distribution of drugs in a non-profit mode will be handled by a new brand: Impact.
July 11, meeting of the Transparency Council.
Novavax announced that NVX-CoV2373 COVID-19 vaccine has been recommended for Extended Conditional Marketing Authorization (CMA) in the European Union (EU) for adolescents 12-17 years of age. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its...
In Journal of Laws The Ministry of Health published an Notice of the Minister of Health of 27 June 2022 on the list of medicinal products, foodstuffs for particular nutritional uses and medical devices at risk of unavailability in the territory of the Republic of Poland.
The US Food and Drug Administration (FDA) has approved a 15-valent pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease in infants and children.
On the website of the Ministry of Health, a Draft announcement of the Minister of Health on the list of reimbursed drugs, foodstuffs for particular nutritional uses and medical devices has been published, which will enter into force on July 1, 2022. Comments to the draft Notice of the Minister of...
The next meeting of the Transparency Council will take place on June 20.
Five scientific abstracts on Vertex's cystic fibrosis drugs were presented at the 45th Conference of the European Cystic Fibrosis Society (ECFS) held in Rotterdam, the Netherlands, on June 8-11, 2022. The presented analysis of data collected in the US CF Foundation Patient Registry CFFPR covering...
The next meeting of the Transparency Council will be held on June 13 (Monday).
TZF Polfa S.A. joined the group of members of PASMI - Employers' Union "Polish Union of Drug Manufacturers Without Prescription".
On Monday, June 6, another meeting of the Transparency Council.
The guest of Medexpress is prof. Monika Adamczyk-Sowa, president of the Multiple Sclerosis and Neuroimmunology Section of the PTN.
Folded in May this year. by National Medicines Manufacturers to the European Parliament, a petition to support the production of ingredients for the production of drugs in the EU was approved and will be considered in the fall of this year.
On May 30 (Monday) another meeting of the Transparency Council.
On May 23 (Monday) another meeting of the Transparency Council.
We publish the position of the Polish Society of Rheumatology on the availability of innovative therapies for patients with rheumatic diseases
On May 9 (Monday) another meeting of the Transparency Council.
The Main Pharmaceutical Inspector decided to suspend the national market of the medicinal product: Sumilar HCT (Ramiprilum + Amlodipinum + Hydrochlorothiazidum), 5 mg + 5 mg + 12.5 mg, hard capsules batch number: 12574261 expiry date: 04.2023 . The responsible party is Sandoz GmbH,...
The May reimbursement list included two highly anticipated treatments: polatuzumab vedotin and Car-T for patients with refractory and relapsed B-cell lymphoma who had no previous treatment options.
On April 25 (Monday) another meeting of the Transparency Council.
The European Commission approves the use of abemaciclib in combination with endocrine therapy for the adjuvant treatment of adult patients with hormone receptor-positive (HR) early stage breast cancer and non-expressing human epidermal growth factor receptor 2 (HER2) type 2 receptor with lymph...
© 2023 Medexpress. All Rights Reserved
